MEDICINAL CANNABIS WHOLESALER LICENSING & SETUP
Become a medicinal cannabis supplier in Australia
HCPA helps you choose the right sourcing model, understand the licences and approvals that apply, establish your supply chain and prepare to bring medicinal cannabis products to the Australian market.

There is no single medicinal cannabis supplier licence that covers every business model. In most cases, a business wholesaling medicinal cannabis will need a wholesale licence or authority from the state or territory where it operates. Your pathway depends on whether you source products in Australia or overseas, the products involved, where they are stored and how they will be supplied.
Imported medicinal cannabis requires permission from the Office of Drug Control, while state or territory medicines and poisons requirements may also apply. For most unapproved medicinal cannabis products, the Australian sponsor also remains responsible for product quality and lawful supply through the relevant access pathway. Learn about medicinal cannabis supply and distribution through the TGA.
HCPA can help you determine the right wholesale, import and supply pathway before you commit to suppliers, products or significant inventory.
Still deciding whether medicinal cannabis supply is the right opportunity for you?
Supplying medicinal cannabis can offer a lower-infrastructure route into the sector than establishing a cultivation or manufacturing operation. Businesses may source products locally, import from overseas manufacturers or develop their own private-label range.
The commercial risk is often inventory rather than infrastructure. Overseas manufacturers may require much larger minimum orders, while a locally sourced range can allow a supplier to test demand with less capital tied up in stock.
Product selection also needs to happen before licensing and logistics are treated as the main project. Price, differentiation, shelf life, minimum order quantities and supplier capability can all affect whether the range remains commercially attractive once it reaches Australia.
HCPA can help you compare your options, understand the likely investment and assess how your proposed range could fit into the Australian market before you commit to stock.
Who is well suited to becoming a medicinal cannabis supplier?
A strong supplier needs commercial capability across sales, marketing and business development, including relationships with authorised buyers, clinics, prescribers and pharmacies, as well as an understanding of regulated medicines, product quality and controlled supply chains.
What do you need to become a medicinal cannabis wholesaler?
The first decision is not which medicinal cannabis licence application to complete. It is what you intend to supply and where those products will come from.
That decision shapes the licences and permissions you need, your product documentation, storage arrangements, import pathway, investment and supply-chain partners.

1. Choose your sourcing model
Start by deciding whether you will source an existing Australian product, import from an overseas manufacturer or develop a range under your own brand.
Domestic sourcing can offer smaller initial orders and a simpler supply chain. Importing may provide access to different products and pricing, but it introduces additional regulatory steps and can require larger stock commitments.
Before committing, consider the product’s point of difference, minimum order quantities, shelf life, expected margin, supplier capability and likely demand.
HCPA’s experience suggests a leaner domestic-sourcing model may be possible from around $40,000–$50,000, while imported ranges can require substantially more once inventory, logistics, licensing, distribution and market-entry costs are included. These are broad planning estimates only and do not include HCPA consulting fees.
For overseas products, confirm the manufacturing and quality documentation before agreeing to a large order. A commercially attractive product can still be unsuitable if the manufacturer cannot provide the evidence needed for the Australian market.
HCPA can help assess potential products and suppliers before you commit significant capital.
2. Establish your wholesale pathway
The requirements depend on where your business operates, where medicines will be stored and the scheduled substances involved.
In most cases, a medicinal cannabis wholesaler will need a wholesale licence or other authority under the medicines and poisons framework of the relevant state or territory. These approvals can govern the possession, storage and wholesale supply of Schedule 4 and Schedule 8 medicines and are separate from Commonwealth requirements applying to importation and unapproved therapeutic goods.
For most unapproved medicinal cannabis products, the sponsor must maintain the required control over supply even where a third party assists with storage or distribution. The TGA guidance on importing, manufacturing and supplying medicinal cannabis explains how these arrangements can operate.
Most medicinal cannabis products are also unapproved therapeutic goods. They are supplied through authorised access pathways such as the Special Access Scheme and Authorised Prescriber pathway rather than simply entering ordinary wholesale distribution.
HCPA can help identify the requirements for your jurisdiction and establish a compliant supply and storage model.
3. Obtain import permissions where required
If your model involves overseas products, you will need to address the ODC import pathway.
Medicinal cannabis requires both an import licence and permit before importation. The licence can be valid for up to 12 months, while a separate permit is required for each shipment and relevant substance or preparation type. Review the ODC medicinal cannabis import requirements.
Your overseas supplier must also have the appropriate authority to export, and the import process requires information about the proposed products and quantities.
An ODC import licence therefore does not allow unlimited products or shipments to enter Australia.
HCPA can help prepare the applicable licence and permit applications and coordinate the information required from overseas suppliers.
4. Verify quality and prepare for supply
Before committing to a product range, the supplier needs to confirm that the product and manufacturer can meet relevant Australian requirements.
Depending on the product, dosage form and supply pathway, these can include TGO 93 medicinal cannabis quality requirements, TGO 91 labelling requirements, TGO 100 microbiological standards and requirements under the Poisons Standard. The sponsor is responsible for identifying the standards that apply and ensuring compliance before importation and supply.
Before market entry, review documentation covering:
- certificates of analysis
- manufacturing and GMP evidence
- product specifications
- labels and packaging
- batch and microbiological testing
- storage requirements
- expiry and shelf life
- quality, complaint and recall procedures
HCPA’s experience identifies incomplete or unsuitable supplier documentation as a common early problem. Selecting an overseas manufacturer before confirming its GMP status, testing capabilities and product records can cause delays or make the product unsuitable for supply in Australia.
HCPA can review the product documentation and coordinate the regulatory, quality and supply-chain requirements before market entry.
Why work with HCPA when becoming a medicinal cannabis supplier?
Medicinal cannabis supply brings together product selection, sponsor responsibilities, licensing, imports, quality and logistics. The decisions are connected, so choosing the product first and trying to solve the regulatory pathway afterwards can be expensive.
A supplier can complete the required applications and still have a weak commercial model if minimum order quantities are too high, shelf life is too short or too much capital is committed before demand has been tested.
HCPA helps you consider these decisions before committing heavily to stock. We can assess the regulatory pathway, review proposed products and suppliers, prepare licence and import applications and help establish suitable manufacturing, storage and distribution relationships.
Whether you are comparing Australian products, evaluating an overseas manufacturer or developing a private-label range, HCPA can help identify what needs to be resolved before orders are placed.
Backed by HCPA’s Compliance Guarantee
Eligible HCPA registration services are backed by the Compliance Guarantee. If approval is not achieved due to HCPA’s compliance work following three attempts, HCPA provides a full refund and you keep the work completed.
How HCPA helps you become a medicinal cannabis wholesaler
Define your supply model
HCPA helps you compare domestic sourcing, importing and private-label options and assess the products, investment and partners required.
Prepare your licences
We identify the applicable state, territory and federal pathways and help prepare licence applications, import permissions and supporting documentation.
Establish your supply chain
HCPA can help review manufacturers, product documentation, storage and distribution arrangements and connect you with relevant industry partners.
Prepare for market entry
We review the product, manufacturer documentation, import pathway and supply arrangements so the proposed range is ready to enter the Australian market.
Our experience helping businesses enter regulated markets
businesses supported
industry consultants
first-time approval rate
client revenue generated
HCPA’s medicinal cannabis capability combines regulatory, pharmaceutical, supply-chain and commercial experience.
Our team has supported medicinal cannabis suppliers with licensing, product sourcing, import pathways, storage and distribution arrangements and new product launches.
For new suppliers, that experience is particularly useful before stock is committed, when changes to the manufacturer, range, storage model or import strategy are still easier to make.
Frequently asked questions about becoming a medicinal cannabis supplier
How do I become a medicinal cannabis importer or wholesaler supplier in Australia?
Start by deciding what you intend to supply and whether it will be sourced domestically or imported.
You will generally need to establish the applicable state or territory wholesale licence or authority, along with your storage model and product quality requirements. If you intend to import, the ODC also requires appropriate import permissions before medicinal cannabis enters Australia.
HCPA can help map these requirements into one implementation plan.
Should a medicinal cannabis supplier import existing products or develop its own range?
Both can work.
Importing an existing product can provide access to established overseas manufacturers and potentially competitive production costs, but minimum order quantities, international logistics and import requirements can increase the upfront commitment.
Developing your own range can give the business more control over positioning, formulation and branding, but requires suitable manufacturing partners and stronger product-development oversight.
A third option is sourcing from an Australian manufacturer. This can allow smaller initial orders and make it easier to test demand before committing to larger volumes.
The right choice depends on your capital, target market, margins and route to market.
What licences does a medicinal cannabis wholesaler need?
There is no single supplier licence that applies to every business.
In most cases, a wholesale licence or authority will be required from the state or territory where the business operates.
Requirements depend on the product, scheduled substance, state or territory, storage arrangements and whether the business imports.
Importing medicinal cannabis also requires the applicable ODC import licence and consignment-specific permits.
HCPA can help determine the pathway based on your proposed range and supply model.
Do I need my own warehouse to become a medicinal cannabis supplier?
Not necessarily.
A supplier may be able to use an appropriately authorised third-party storage or distribution provider rather than establishing its own facility.
However, for unapproved medicinal cannabis, the Australian sponsor still needs to retain the level of product control required by the therapeutic goods rules. The TGA explains these third-party distribution arrangements here.
What is the difference between an ODC import licence and an import permit?
The licence authorises the business to undertake the relevant import activity during the licence period.
A permit applies to the particular consignment. The ODC requires the import licence to be obtained before an import permit can be granted, and a new permit is required for each consignment. See the ODC import permit guidance.
How much does it cost to become a medicinal cannabis supplier?
There is no fixed startup cost because investment depends heavily on the sourcing model, minimum order quantities and approach to storage, distribution and market entry.
Based on HCPA’s experience, a leaner model using domestically sourced products may be possible from around $40,000–$50,000.
An importing model can require considerably more capital. Overseas minimum orders, inventory, licensing, logistics, storage, distribution and market development can push investment well into six figures.
These are broad planning estimates and should be tested against the proposed range and business model.
Can I source medicinal cannabis from Australian manufacturers?
Yes.
Domestic sourcing can reduce international logistics and may allow lower initial order quantities, making it useful for testing the market before committing to a larger imported range.
It can also allow the business to test demand before committing to larger quantities.
The products and supply arrangements still need to meet the applicable therapeutic goods and medicines requirements.
What should I check before committing to a product?
Check the regulatory documentation and the commercial terms at the same time.
Review manufacturing and GMP evidence, certificates of analysis, product specifications, quality testing, shelf life, minimum order quantities and the supplier’s authority to manufacture or export the product.
A low purchase price may not remain attractive if the minimum order is large or the remaining shelf life is too short to sell the stock comfortably.
What is the Australian sponsor responsible for?
For an unapproved medicinal cannabis product, the Australian sponsor carries important responsibilities for the product supplied in Australia.
These include ensuring applicable quality requirements are met and maintaining the required control over the lawful supply pathway, even where manufacturers, storage providers or other third parties perform parts of the supply chain.
Does an ODC import licence let me import unlimited medicinal cannabis?
No.
An ODC import licence allows the holder to apply for import permits. It does not provide unlimited authority to import medicinal cannabis.
A separate permit is required for each consignment, and the products, quantities and substances being imported must fall within the applicable approvals.
Related medicinal cannabis supplier resources
Maintain product and supply compliance
Need help with TGO 93, GMP or sponsor obligations?
Grow your medicinal cannabis product business
Looking to expand your range or increase product uptake?
Prioritise products with a clear market position, strengthen clinic and pharmacy relationships and manage inventory, expiry risk and margins as the portfolio grows.
Start growingWhat Our Clients Say

